9-ING-41 Uses, Dosage, Side Effects and more
9-ING-41 is under investigation in clinical trial NCT04218071 (Actuate 1901: 9-ING-41 in Myelofibrosis).
| Trade Name | 9-ING-41 |
| Generic | 9-ING-41 |
| Type | |
| Formula | C22H13FN2O5 |
| Weight | Average: 404.353 Monoisotopic: 404.08084969 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
